RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.9413
-0.0087 (-0.92%)
At close: Dec 5, 2025, 4:00 PM EST
0.9900
+0.0487 (5.17%)
After-hours: Dec 5, 2025, 6:40 PM EST
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $34.50 million as of December 5, 2025. Its market cap has increased by 29.49% in one year.
Market Cap
34.50M
Enterprise Value
24.69M
1-Year Change
29.49%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $34.50M, a decrease of -49.74%. That is a compound annual growth rate of -14.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 34.50M | 11.42% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |